(MedPage Today) — The Sapien M3 transcatheter mitral valve replacement system won FDA approval — making it the first on the market to utilize a transseptal approach — for the treatment of symptomatic moderate-to-severe or severe mitral regurgitation…
Source link : https://www.medpagetoday.com/cardiology/generalcardiology/119213
Author :
Publish date : 2025-12-30 15:25:00
Copyright for syndicated content belongs to the linked Source.
